Assignee
INTERMUNE INC
US40 patents
Top patents by PatentIndex Score
US7491794B2Feb 17, 2009
Macrocyclic compounds as inhibitors of viral replication
INTERMUNE INC147 citations97
US7728013B2Jun 1, 2010
Method of modulating stress-activated protein kinase system
INTERMUNE INC40 citations95
US7767700B2Aug 3, 2010
Method of providing pirfenidone therapy to a patient
INTERMUNE INC26 citations92
US7829665B2Nov 9, 2010
Macrocyclic inhibitors of hepatitis C virus replication
INTERMUNE INC27 citations91
US7816383B1Oct 19, 2010
Methods of administering pirfenidone therapy
INTERMUNE INC27 citations91
US7635707B1Dec 22, 2009
Pirfenidone treatment for patients with atypical liver function
INTERMUNE INC15 citations91
US7566729B1Jul 28, 2009
Modifying pirfenidone treatment for patients with atypical liver function
INTERMUNE INC37 citations91
US7696236B2Apr 13, 2010
Method of providing pirfenidone therapy to a patient
INTERMUNE INC32 citations88
US7407973B2Aug 5, 2008
Use of pirfenidone in therapeutic regimens
INTERMUNE INC36 citations88
US8013002B2Sep 6, 2011
Methods of administering pirfenidone therapy
INTERMUNE INC9 citations83
US7910610B1Mar 22, 2011
Methods of administering pirfenidone therapy
INTERMUNE INC10 citations83
US10376497B2Aug 13, 2019
Anti-fibrotic pyridinones
INTERMUNE INC5 citations82
US9675593B2Jun 13, 2017
Anti-fibrotic pyridinones
INTERMUNE INC10 citations82
US9359379B2Jun 7, 2016
Anti-fibrotic pyridinones
INTERMUNE INC12 citations82
US8969347B2Mar 3, 2015
Compounds and methods for treating inflammatory and fibrotic disorders
INTERMUNE INC10 citations82
US9290450B2Mar 22, 2016
Compounds and methods for treating inflammatory and fibrotic disorders
INTERMUNE INC5 citations81
US8753679B2Jun 17, 2014
Capsule formulation of pirfenidone and pharmaceutically acceptable excipients
INTERMUNE INC4 citations81
US8383150B2Feb 26, 2013
Granulate formulation of pirfenidone and pharmaceutically acceptable excipients
INTERMUNE INC9 citations81
US7988994B2Aug 2, 2011
Capsule formulation of pirfenidone and pharmaceutically acceptable excipients
INTERMUNE INC10 citations81
US7767225B2Aug 3, 2010
Capsule formulation of pirfenidone and pharmaceutically acceptable excipients
INTERMUNE INC11 citations81
US7781474B2Aug 24, 2010
Inhibitors of hepatitis C virus replication
INTERMUNE INC7 citations72
US10898474B2Jan 26, 2021
Anti-fibrotic pyridinones
INTERMUNE INC1 citations71
US10233195B2Mar 19, 2019
Anti-fibrotic pyridinones
INTERMUNE INC4 citations71
US9561217B2Feb 7, 2017
Pharmaceutical composition containing as an active ingredient 5-methyl-1-phenyl-2-(1H)-pyridone
INTERMUNE INC2 citations71
US8778947B2Jul 15, 2014
Methods of administering pirfenidone therapy
INTERMUNE INC5 citations69
US9527816B2Dec 27, 2016
Method of modulating stress-activated protein kinase system
INTERMUNE INC1 citations61
US7638488B2Dec 29, 2009
Use of alpha-glucosidase inhibitors to treat alphavirus infections
INTERMUNE INC3 citations61
US9017722B2Apr 28, 2015
Pharmaceutical composition containing as an active ingredient 5-methyl-1-phenyl-2-(1H)-pyridone
INTERMUNE INC2 citations60
US8048862B2Nov 1, 2011
Macrocyclic inhibitors of hepatitis C virus replication
INTERMUNE INC3 citations60
US6936695B1Aug 30, 2005
Manufacture and expression of large structural genes
INTERMUNE INC2 citations59
US6936694B1Aug 30, 2005
Manufacture and expression of large structural genes
INTERMUNE INC2 citations59
US10544161B2Jan 28, 2020
Anti-fibrotic pyridinones
INTERMUNE INC0 citations50
USRE47142ENov 27, 2018
Compounds and methods for treating inflammatory and fibrotic disorders
INTERMUNE INC0 citations50
US10010536B2Jul 3, 2018
Method of modulating stress-activated protein kinase system
INTERMUNE INC0 citations50
US7932267B2Apr 26, 2011
Use of α-glucosidase inhibitors to treat alphavirus infections
INTERMUNE INC1 citations50
US9682071B2Jun 20, 2017
Methods of improving microvascular integrity
INTERMUNE INC0 citations48
US7932277B2Apr 26, 2011
Peptide inhibitors of hepatitis C virus replication
INTERMUNE INC2 citations48
USRE39821ESep 4, 2007
Manufacture and expression of large structural genes
INTERMUNE INC0 citations48
US6939947B2Sep 6, 2005
N1-modified glycopeptides
INTERMUNE INC0 citations48
US9726677B2Aug 8, 2017
Proteomic IPF markers
INTERMUNE INC0 citations28